2 High-Growth Stocks to Buy Under $10

By Mijuško Šibalić, Stock Market Writer and Stock Researcher
November 12, 2025 6:26 AM UTC
2 High-Growth Stocks to Buy Under $10

The tumult of last week seems to have passed — with the U.S. government shutdown apparently set to conclude soon, investors piled back into the markets, erasing most of the losses registered between November 3 and November 7.

At this juncture, a return to the status quo — which is to say, a bull market, seems like the likeliest outcome. The flow of fresh economic data will likely resume soon, which will provide an additional level of clarity going forward.

So, in short — last week was no turning point, and we’re still on an upward trajectory until proven otherwise. That being said, the government reopening isn’t a particularly bullish catalyst either.

In moments that lack a clear driving force, staying put and biding your time might seem like the wisest choice — but right now, that would be tantamount to leaving gains on the table.

Instead, what you should do is get back to the basics — find stocks with solid fundamentals, good growth prospects, and fair valuations. A good place to start might be our…

Under $10 Stock Strategy

Our proprietary rating system uses 115 distinct factors to evaluate stocks. That insight is distilled into an intuitive, straightforward metric — a Zen Rating.

We track roughly 4,600 stocks, and only the top 5% are given a Zen Rating of A, equivalent to a Strong Buy rating.

That leaves you with roughly 230 stocks to consider on any given day — and while that’s certainly a good start, you can narrow the search down even further through our Zen Strategies.

Simply put, these are 11 carefully curated portfolios. Each consists of just 7 stocks, carefully chosen to provide outsized returns.

With the goal of making scaling into positions easier in these uncertain times, this time around, we’ll be taking a look at our Under $10 Stock Strategy.

This portfolio has an all-time annual return of 34.54% — however, it has also had some truly exceptional years, such as 2022, where it delivered a 95.56% gain compared to the S&P 500’s 18.18% loss. Thus far in 2025, the strategy is outperforming the wider market — so we have every reason to be optimistic going forward.

Most investors will keep piling in on already overcrowded and overcovered names — while great sub $10 stocks glide under the radar. Now, you’ll get a chance to see 2 interesting new additions to one of our top-performing portfolios…

Bausch Health (BHC)

Our first entry, Bausch Health, develops, manufactures, and sells a wide range of medications and medical devices. BHC ranks in the top 2% of the stocks that we track, but it has seen some tough times — it  is down 17% YTD, but a 37.87% rally over the past 6 months seems to suggest that we’re in the midst of a turnaround.

That narrative was further boosted by Bausch’s latest quarterly report, from October 29. EPS came in at $1.15, ahead of consensus estimates, which were pegged at $1.05. This marks the second quarter of beating estimates — last time around, we also had significant outperformance, with EPS of $1.02 versus estimates of $0.90.

Even better, the company raised full-year guidance for revenue, adjusted EBITDA, and adjusted operating cash flow. In fact, analysts are expecting to see EPS grow by an exceptional 57.91% per year — which places BHC in the 87th percentile of stocks when it comes to Growth.

Bausch Health also ranks in the top 2% of stocks in terms of its Artificial Intelligence rating — meaning that a neural network trained on more than two decades of market data has singled it out as a likely outperformer going forward.

Best of all, however, is BHC’s great valuation — at a P/E of 6.86x and a PEG ratio of just 0.12x, the stock is incredibly cheap, particularly relative to its growth prospects — so now is a great time to snatch it up before everyone else catches on.

Udemy (UDMY)

Our next entry is the go-to destination for online education, which is currently enjoying the benefits of an AI-upskilling deluge. Udemy ranks in the top 2% of the stocks that we track — 73rd overall, out of roughly 4,600 — and for good reason. UDMY has beaten analyst estimates for 5 quarters in a row.

Despite that, the stock is down 36.17% YTD — and has lost 17% in value since its last quarterly report on October 29. That report saw EPS growth on a YoY basis of 85.71% — and while that’s a far cry from the triple-digit growth of previous quarters, this is simply the result of a maturing business model. No boom lasts forever — but that’s no reason to disregard growth that is still stellar. In fact, Udemy ranks in the top 15% with regard to its Growth rating.

That’s not everything that UDMY has going for it — its impressive balance sheet puts it in the 86th percentile according to Financials, while a thorough review of 21 factors tied to its valuation places it in the top 6% in terms of Value.

Udemy is also in the top 6% of stocks when looking at Sentiment. Based on the coverage of 5 Wall Street analysts, the average price target for the stock is $10.20, which implies a 98.06% upside.

Simply put, this is a healthy, growing business that Wall Street has faith in — and it’s only a matter of time before the market’s undue pessimism about UDMY is rectified. Since it’s already trading at such a bargain price, it’s wiser to get in on it now rather than waiting for an even more attractive entry point.

Interested In More Great Stock Picks?

The 2 stocks highlighted above are just a fraction of what you get from our proven Under $10 strategy

That’s because each day our system recalibrates — and Zen Strategies members get access to the 7 top Buy the Dip stocks based on 115 different parameters that point to outperformance. 

See all Top 7 Under $10 stocks here > 

However, maybe you want more than just these low priced stocks. Perhaps you would like to see all 11 of our market beating strategies including Growth, Value, Momentum and our coveted AI Factor model. 

Each featuring the top 7 stocks.

Each featuring tremendous performance

We spell it all out in this timely presentation below that lives up to its name:

10 Minutes a Month to Beat the Market > 

What to Do Next?

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.